Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells.

Urso K, Fernández A, Velasco P, Cotrina J, de Andrés B, Sánchez-Gómez P, Hernández-Laín A, Hortelano S, Redondo JM, Cano E.

Sci Rep. 2019 Jun 27;9(1):9361. doi: 10.1038/s41598-019-45731-w.

2.

Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.

Manneh Kopp RA, Sepúlveda-Sánchez JM, Ruano Y, Toldos O, Pérez Núñez A, Cantero D, Hilario A, Ramos A, de Velasco G, Sánchez-Gómez P, Hernández-Laín A.

Clin Transl Oncol. 2019 Mar 15. doi: 10.1007/s12094-019-02070-6. [Epub ahead of print]

PMID:
30877636
3.

Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Kuciak M, Mas C, Borges I, Sánchez-Gómez P, Ruiz I Altaba A.

Sci Rep. 2019 Mar 7;9(1):3891. doi: 10.1038/s41598-019-39473-y.

4.

Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking.

Portela M, Segura-Collar B, Argudo I, Sáiz A, Gargini R, Sánchez-Gómez P, Casas-Tintó S.

Glia. 2019 Feb;67(2):404-417. doi: 10.1002/glia.23551. Epub 2018 Dec 2.

PMID:
30506943
5.

Dacomitinib: an investigational drug for the treatment of glioblastoma.

Sepúlveda JM, Sánchez-Gómez P, Vaz Salgado MÁ, Gargini R, Balañá C.

Expert Opin Investig Drugs. 2018 Oct;27(10):823-829. doi: 10.1080/13543784.2018.1528225. Epub 2018 Oct 5. Review.

PMID:
30247945
6.

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.

López-Valero I, Saiz-Ladera C, Torres S, Hernández-Tiedra S, García-Taboada E, Rodríguez-Fornés F, Barba M, Dávila D, Salvador-Tormo N, Guzmán M, Sepúlveda JM, Sánchez-Gómez P, Lorente M, Velasco G.

Biochem Pharmacol. 2018 Nov;157:266-274. doi: 10.1016/j.bcp.2018.09.007. Epub 2018 Sep 7.

7.

The Netrin-4/Laminin γ1/Neogenin-1 complex mediates migration in SK-N-SH neuroblastoma cells.

Villanueva AA, Puvogel S, Lois P, Muñoz-Palma E, Ramírez Orellana M, Lubieniecki F, Casco Claro F, Gallegos I, García-Castro J, Sanchez-Gomez P, Torres VA, Palma V.

Cell Adh Migr. 2019 Dec;13(1):33-40. doi: 10.1080/19336918.2018.1506652. Epub 2018 Aug 30.

8.

Effect of psychiatric symptoms and quality of life on cognitive performance in HCV patients.

García-Guerrero MA, Sánchez Gómez P, Peña Lasa J, Portu Zapirain J, Elizagárate Zabala E, Gorria Bernal V, Ojeda Del Pozo N.

Rev Psiquiatr Salud Ment. 2018 Aug 3. pii: S1888-9891(18)30060-0. doi: 10.1016/j.rpsm.2018.06.003. [Epub ahead of print] English, Spanish.

PMID:
30082230
9.

High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response.

Arrizabalaga O, Moreno-Cugnon L, Auzmendi-Iriarte J, Aldaz P, Ibanez de Caceres I, Garros-Regulez L, Moncho-Amor V, Torres-Bayona S, Pernía O, Pintado-Berninches L, Carrasco-Ramirez P, Cortes-Sempere M, Rosas R, Sanchez-Gomez P, Ruiz I, Caren H, Pollard S, Garcia I, Sacido AA, Lovell-Badge R, Belda-Iniesta C, Sampron N, Perona R, Matheu A.

Oncogenesis. 2017 Dec 14;6(12):401. doi: 10.1038/s41389-017-0003-9.

10.

Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.

Sepúlveda-Sánchez JM, Vaz MÁ, Balañá C, Gil-Gil M, Reynés G, Gallego Ó, Martínez-García M, Vicente E, Quindós M, Luque R, Ramos A, Ruano Y, Pérez-Segura P, Benavides M, Sánchez-Gómez P, Hernández-Laín A.

Neuro Oncol. 2017 Oct 19;19(11):1522-1531. doi: 10.1093/neuonc/nox105.

11.

Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.

Ayuso JM, Monge R, Martínez-González A, Virumbrales-Muñoz M, Llamazares GA, Berganzo J, Hernández-Laín A, Santolaria J, Doblaré M, Hubert C, Rich JN, Sánchez-Gómez P, Pérez-García VM, Ochoa I, Fernández LJ.

Neuro Oncol. 2017 Apr 1;19(4):503-513. doi: 10.1093/neuonc/now230.

12.

The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.

Villanueva AA, Falcón P, Espinoza N, R LS, Milla LA, Hernandez-SanMiguel E, Torres VA, Sanchez-Gomez P, Palma V.

Oncotarget. 2017 Feb 7;8(6):9767-9782. doi: 10.18632/oncotarget.14213.

13.

Influence of water stress and storage time on preservation of the fresh volatile profile of three basil genotypes.

Jordán MJ, Quílez M, Luna MC, Bekhradi F, Sotomayor JA, Sánchez-Gómez P, Gil MI.

Food Chem. 2017 Apr 15;221:169-177. doi: 10.1016/j.foodchem.2016.10.059. Epub 2016 Oct 13.

PMID:
27979148
14.

ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.

Talamillo A, Grande L, Ruiz-Ontañon P, Velasquez C, Mollinedo P, Torices S, Sanchez-Gomez P, Aznar A, Esparis-Ogando A, Lopez-Lopez C, Lafita C, Berciano MT, Montero JA, Vazquez-Barquero A, Segura V, Villagra NT, Pandiella A, Lafarga M, Leon J, Martinez-Climent JA, Sanz-Moreno V, Fernandez-Luna JL.

Oncogene. 2017 Mar 23;36(12):1733-1744. doi: 10.1038/onc.2016.341. Epub 2016 Sep 19.

PMID:
27641332
15.

Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media.

García-Romero N, González-Tejedo C, Carrión-Navarro J, Esteban-Rubio S, Rackov G, Rodríguez-Fanjul V, Oliver-De La Cruz J, Prat-Acín R, Peris-Celda M, Blesa D, Ramírez-Jiménez L, Sánchez-Gómez P, Perona R, Escobedo-Lucea C, Belda-Iniesta C, Ayuso-Sacido A.

Oncotarget. 2016 Oct 4;7(40):65888-65901. doi: 10.18632/oncotarget.11676.

16.

[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].

Zahonero C, Sepúlveda JM, Sánchez-Gómez P.

Rev Neurol. 2015 Jul 16;61(2):85-93. Review. Spanish.

PMID:
26156444
17.

High genetic diversity declines towards the geographic range periphery of Adonis vernalis, a Eurasian dry grassland plant.

Hirsch H, Wagner V, Danihelka J, Ruprecht E, Sánchez-Gómez P, Seifert M, Hensen I.

Plant Biol (Stuttg). 2015 Nov;17(6):1233-41. doi: 10.1111/plb.12362. Epub 2015 Jul 14.

PMID:
26122089
18.

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

Zahonero C, Aguilera P, Ramírez-Castillejo C, Pajares M, Bolós MV, Cantero D, Perez-Nuñez A, Hernández-Laín A, Sánchez-Gómez P, Sepúlveda JM.

Mol Cancer Ther. 2015 Jul;14(7):1548-58. doi: 10.1158/1535-7163.MCT-14-0736. Epub 2015 May 4.

19.

Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.

González-Gómez P, Crecente-Campo J, Zahonero C, de la Fuente M, Hernández-Laín A, Mira H, Sánchez-Gómez P, Garcia-Fuentes M.

Oncotarget. 2015 May 10;6(13):10950-63.

20.

DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis.

Fernández-Martínez P, Zahonero C, Sánchez-Gómez P.

Mol Cell Oncol. 2015 Jan 30;2(1):e970048. doi: 10.4161/23723548.2014.970048. eCollection 2015 Jan-Mar. Review.

21.

Shoc2/Sur8 protein regulates neurite outgrowth.

Leon G, Sanchez-Ruiloba L, Perez-Rodriguez A, Gragera T, Martinez N, Hernandez S, Anta B, Calero O, Garcia-Dominguez CA, Dura LM, Peña-Jimenez D, Castro J, Zarich N, Sanchez-Gomez P, Calero M, Iglesias T, Oliva JL, Rojas JM.

PLoS One. 2014 Dec 16;9(12):e114837. doi: 10.1371/journal.pone.0114837. eCollection 2014.

22.

EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Zahonero C, Sánchez-Gómez P.

Cell Mol Life Sci. 2014 Sep;71(18):3465-88. doi: 10.1007/s00018-014-1608-1. Epub 2014 Mar 27. Review.

PMID:
24671641
23.

Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Pozo N, Zahonero C, Fernández P, Liñares JM, Ayuso A, Hagiwara M, Pérez A, Ricoy JR, Hernández-Laín A, Sepúlveda JM, Sánchez-Gómez P.

J Clin Invest. 2013 Jun;123(6):2475-87. doi: 10.1172/JCI63623. Epub 2013 May 1.

24.

Chemical composition and antiradical activity of the essential oil from Satureja intricata, S. obovata and their hybrid Satureja x delpozoi.

Jordán MJ, Sánchez-Gómez P, Jiménez JF, Quílez M, Sotomayor JA.

Nat Prod Commun. 2010 Apr;5(4):629-34.

PMID:
20433087
25.

Bioassay-guided isolation of an anti-ulcer chromene from Eupatorium aschenbornianum: role of nitric oxide, prostaglandins and sulfydryls.

Sánchez-Mendoza ME, Reyes-Trejo B, Sánchez-Gómez P, Rodríguez-Silverio J, Castillo-Henkel C, Cervantes-Cuevas H, Arrieta J.

Fitoterapia. 2010 Jan;81(1):66-71. doi: 10.1016/j.fitote.2009.07.009. Epub 2009 Aug 3.

PMID:
19651191
26.

The phylogeographical history of the Iberian steppe plant Ferula loscosii (Apiaceae): a test of the abundant-centre hypothesis.

Pérez-Collazos E, Sanchez-Gómez P, Jiménez F, Catalán P.

Mol Ecol. 2009 Mar;18(5):848-61. doi: 10.1111/j.1365-294X.2008.04060.x.

PMID:
19207254
27.

[Suprapubic pain in a 14 year old schoolchild].

Sánchez Gómez P, Lajara Marco F, Ricon Recarey FJ.

An Pediatr (Barc). 2008 May;68(5):536-8. Spanish. No abstract available.

28.

Genetic variability in a narrow endemic snapdragon (Antirrhinum subbaeticum, Scrophulariaceae) using RAPD markers.

Jiménez JF, Sánchez-Gómez P, Güemes J, Werner O, Rosselló JA.

Heredity (Edinb). 2002 Nov;89(5):387-93.

Supplemental Content

Loading ...
Support Center